vimarsana.com

Page 3 - Office Of Biostatistics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Waited Months to Alert Public to Possible COVID-19 Vaccine Safety Issues, Researchers Disclose

FDA explains how to use secondary endpoints in clinical trials to show efficacy | Hogan Lovells

The U.S. Food and Drug Administration (FDA) recently finalized the guidance “Multiple Endpoints in Clinical Trials,” which advises drug sponsors on how to separate analyses of primary.

vimarsana © 2020. All Rights Reserved.